News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Elizabeth D. Sharpe, MD

Articles by Elizabeth D. Sharpe, MD

An Economic Analysis of Switching to Latanoprost from a Beta-Blocker or adding Brimonidine or Latanoprost to a Beta-Blocker in Open-Angle Glaucoma or Ocular Hypertension

ByWilliam C. Stewart, MD,Jessica Leech, BS,Elizabeth D. Sharpe, MD,John Kulze, MD,John Ellyn, MD,Douglas G. Day, MD

August 1st 2002

Latest Updated Articles

An Economic Analysis of Switching to Latanoprost from a Beta-Blocker or adding Brimonidine or Latanoprost to a Beta-Blocker in Open-Angle Glaucoma or Ocular Hypertension
Published: August 1st 2002 | Updated:

Trending on AJMC

Bills to Address Expiring ACA Subsidies Fail to Pass Senate

Deprescribing Antidepressants Safely: New Evidence Supports Gradual Taper With Therapy

T-DXd Regimens Show Better Tolerability, Manageable Safety in High-Risk, HER2-Positive Early Breast Cancer

Severe RSV Risk Factors Prevalent Among Vaccine-Ineligible Patients

Treatment Burdens in Traditional Medicare and Medicare Advantage

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.